Inactive Instrument

Green Cross Cell Corporation Stock

Equities

A031390

KR7031390008

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Dynamic Chart
Green Cross Cell Corporation(KOSDAQ:A031390) dropped from S&P Global BMI Index CI
Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders. CI
Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW 510 billion. CI
Tranche Update on Green Cross Cell corporation's Equity Buyback Plan announced on March 20, 2019. CI
Green Cross Cell corporation's Equity Buyback announced on March 20, 2019, has closed with 40,000 shares, representing 0.34% for KRW 2,001.4 million. CI
Green Cross Cell corporation announces an Equity Buyback for 40,000 shares. CI
Green Cross Cell corporation authorizes a Buyback Plan. CI
Sistema, Medsi and RDIF Sign Agreement with South Korean Biotechnology Company Green Cross Cell CI
An undisclosed buyer cancelled the acquisition of Korea High Tech Co., Ltd. from Green Cross Cell corporation. CI
Green Cross Cell corporation completed the acquisition of additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd.. CI
Green Cross Cell corporation agreed to acquire additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd.. CI
Green Cross Cell corporation cancelled the acquisition of CT (cell therapy) business from Green Cross Corporation. CI
Green Cross Cell corporation announced that it has received KRW 60 billion in funding from a group of investors CI
AroCell AB Signs Letter of Intent with Green Cross Cell Corporation CI
Green Cross Cell corporation announced that it expects to receive KRW 60 billion in funding from a group of investors CI
More news
Managers TitleAgeSince
Chief Executive Officer 65 -
Chief Tech/Sci/R&D Officer 59 -
Director/Board Member 59 18-03-15
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer 59 -
Chief Executive Officer 65 -
Director/Board Member 68 17-03-16
More insiders
GREEN CROSS CELL CORPORATION is a Korea-based company mainly engaged in the manufacture of electronic components, through its subsidiaries. The Company operates in two business divisions: IT segment and biotechnology segment. Its IT segment exports computer peripherals to overseas markets, such as liquid crystal display (LCD) monitors. Its biotechnology segment provides immune cell therapy, immune cell cryopreservation service and cord blood cryopreservation service. Through its subsidiaries, it also involves in the manufacture of electronic components, including industrial tapes and others. On April 9, 2013, it changed its name to GREEN CROSS CELL CORPORATION from INNOCELL CORPORATION.
More about the company
  1. Stock Market
  2. Equities
  3. A031390 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW